Citadel Advisors
GRDN

Citadel Advisors’s Guardian Pharmacy Services GRDN Stock Holding History

Citadel Advisors’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Buy
+10,200
New +$395K ﹤0.01% 10265

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Citadel Advisors's GRDN Position: Q2 2026 in Review

Citadel Advisors reduced its Guardian Pharmacy Services (GRDN) stake by 85% in Q2 2026, selling an estimated $19M and leaving 87,775 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #5275.

Citadel Advisors first reported a position in GRDN in Q3 2024 and has held it in 5 quarters since. The position peaked at $21.8M in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Citadel Advisors held 87,775 shares of Guardian Pharmacy Services worth $3.68M as of Q2 2026.
  • Citadel Advisors sold 491,346 Guardian Pharmacy Services shares in Q2 2026, an estimated $19M.
  • Guardian Pharmacy Services made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5275 holding.
  • Citadel Advisors first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 5 quarters since.
  • Citadel Advisors's Guardian Pharmacy Services position peaked at $21.8M in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.